Similar articles

• [Behavior of the human liver during silicosis therapy using polyvinylpyridine-N-oxide (PVNO)].

  Haas P, Huber W. Haas P, et al. Beitr Silikoseforsch Pneumokoniose. 1971;23(3):91-100. Beitr Silikoseforsch Pneumokoniose. 1971. PMID: 5171411 German. No abstract available.
• [Antifibrous action of polyvinyl-pyridine-N-oxides in experimental silicosis].

  Bezrodnykh AA, Kasparov AA, Mazurov VI, Razvodovskiĭ EF, Kochetkova TA. Bezrodnykh AA, et al. Gig Tr Prof Zabol. 1973 Dec;17(12):20-4. Gig Tr Prof Zabol. 1973. PMID: 4789533 Russian. No abstract available.
• [Treatment of experimental silicosis with polyvinyl-pyridine-N-oxide].

  Bogdanskaia NI. Bogdanskaia NI. Gig Tr Prof Zabol. 1973 May;17(5):22-5. Gig Tr Prof Zabol. 1973. PMID: 4771393 Russian. No abstract available.
• [Modern treatment of scleroma and its clinical aspects].

  Bariliak RA. Bariliak RA. Zh Ushn Nos Gorl Bolezn. 1969 Jan-Feb;29(1):9-13. Zh Ushn Nos Gorl Bolezn. 1969. PMID: 4913565 Review. Russian. No abstract available.
• [Trials of casual treatment of silicosis].

  Idec-Sadkowska I, Andrzejak R, Antonowicz-Juchniewicz J, Kaczmarek-Wdowiak B. Idec-Sadkowska I, et al. Med Pr. 2006;57(3):271-80. Med Pr. 2006. PMID: 17125034 Review. Polish.